chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Device connection issue, Fatigue, Pain in extremity
Clinical narrative: L arm soreness; very slight tiredness; only slightly placed needle in upper arm when injected; When I received this dose the nurse expired some serum down my arm right before injection/I have always wondered if I really received a full 2 dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (L arm soreness), FATIGUE (very slight tiredness), DEVICE CONNECTION ISSUE (only slightly placed needle in upper arm when injected) and ACCIDENTAL UNDERDOSE (When I received this dose the nurse expired some serum down my arm right before injection/I have always wondered if I really received a full 2 dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Hypothyroidism (Hypothyroid Disease). Concurrent medical conditions included Asthma, Seasonal allergy (spring seasonal), Dust allergy and Allergy to chemicals (some solvents). Concomitant products included ALBUTEROL [SALBUTAMOL] from 1998 to an unknown date, LEVOTHYROXINE from 1997 to an unknown date, COLECALCIFEROL (VIT D [COLECALCIFEROL]) from 2004 to an unknown date and TOCOPHEROL (VIT E [TOCOPHEROL]) from 1998 to an unknown date for an unknown indication.   On 23-Jan-2021 at 9:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021 at 9:45 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021 at 9:45 AM, the patient experienced DEVICE CONNECTION ISSUE (only slightly placed needle in upper arm when injected) and ACCIDENTAL UNDERDOSE (When I received this dose the nurse expired some serum down my arm right before injection/I have always wondered if I really received a full 2 dose). On 20-Feb-2021 at 1:45 PM, the patient experienced PAIN IN EXTREMITY (L arm soreness) and FATIGUE (very slight tiredness). On 20-Feb-2021 at 9:45 AM, DEVICE CONNECTION ISSUE (only slightly placed needle in upper arm when injected) and ACCIDENTAL UNDERDOSE (When I received this dose the nurse expired some serum down my arm right before injection/I have always wondered if I really received a full 2 dose) had resolved. At the time of the report, PAIN IN EXTREMITY (L arm soreness) and FATIGUE (very slight tiredness) had resolved.            There were no other potential causes. It was reported that the previously the patient experienced slight soreness at injection site. The patient would like to thank Moderna for the vaccination.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-437638 (Patient Link).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site mass
Clinical narrative: hives in left arm are really bad; Big knot in the left arm/knot went down; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives in left arm are really bad) and VACCINATION SITE MASS (Big knot in the left arm/knot went down) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, the patient experienced VACCINATION SITE MASS (Big knot in the left arm/knot went down). On an unknown date, the patient experienced URTICARIA (hives in left arm are really bad). At the time of the report, URTICARIA (hives in left arm are really bad) outcome was unknown and VACCINATION SITE MASS (Big knot in the left arm/knot went down) was resolving.            After the booster dose, patient had a big knot in the left arm that appeared on 30-dec-2021 and it went down on 01-jan-2022 but was still there.  It was reported that concomitant medication included 7 or 8 of them. No treatment medication were reported.   This case was linked to MOD-2022-437506 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Rash, Vaccination site erythema, Vaccination site rash
Clinical narrative: Chills; Nausea; rash in her left upper arm where she was vaccinated; hot spot and red at the injection site.; It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.; hot spot and red at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot spot and red at the injection site.), RASH (It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.), VACCINATION SITE ERYTHEMA (hot spot and red at the injection site.), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 91875) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jan-2022, the patient experienced VACCINATION SITE WARMTH (hot spot and red at the injection site.), RASH (It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.) and VACCINATION SITE ERYTHEMA (hot spot and red at the injection site.). On an unknown date, the patient experienced CHILLS (Chills), NAUSEA (Nausea) and VACCINATION SITE RASH (rash in her left upper arm where she was vaccinated). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (hot spot and red at the injection site.), RASH (It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.), VACCINATION SITE ERYTHEMA (hot spot and red at the injection site.), CHILLS (Chills), NAUSEA (Nausea) and VACCINATION SITE RASH (rash in her left upper arm where she was vaccinated) outcome was unknown.     No concomitant medication reported. It was reported that she was given a steroid shoot,pepcid and was prescribed steroid pills.   This case was linked to MOD-2022-437646, MOD-2022-437661 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Chills; Nausea; rash in her left upper arm where she was vaccinated; hot spot and red at the injection site.; It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.; hot spot and red at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot spot and red at the injection site.), RASH (It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.), VACCINATION SITE ERYTHEMA (hot spot and red at the injection site.), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 91875) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jan-2022, the patient experienced VACCINATION SITE WARMTH (hot spot and red at the injection site.), RASH (It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.) and VACCINATION SITE ERYTHEMA (hot spot and red at the injection site.). On an unknown date, the patient experienced CHILLS (Chills), NAUSEA (Nausea) and VACCINATION SITE RASH (rash in her left upper arm where she was vaccinated). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (hot spot and red at the injection site.), RASH (It become a very bad full body rash/The rash expanded to her back, chest head and legs. It was a dark red bumpy rash.), VACCINATION SITE ERYTHEMA (hot spot and red at the injection site.), CHILLS (Chills), NAUSEA (Nausea) and VACCINATION SITE RASH (rash in her left upper arm where she was vaccinated) outcome was unknown.     No concomitant medication reported. It was reported that she was given a steroid shoot,pepcid and was prescribed steroid pills.   This case was linked to MOD-2022-437646, MOD-2022-437661 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: received a full dose of moderna as my booster; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (received a full dose of moderna as my booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (received a full dose of moderna as my booster). At the time of the report, ACCIDENTAL OVERDOSE (received a full dose of moderna as my booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The patient received a full dose of Moderna as their booster dose because their previous pharmacy did not register their 2nd dose to agency, but all info.  No treatment information was provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Product administration error
Clinical narrative: I didn't get the full dose/I don't even think that he got the full dose in me; There was a large drop that went from the injection site down to my elbow; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (I didn't get the full dose/I don't even think that he got the full dose in me) and PRODUCT ADMINISTRATION ERROR (There was a large drop that went from the injection site down to my elbow) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2022, the patient experienced ACCIDENTAL UNDERDOSE (I didn't get the full dose/I don't even think that he got the full dose in me) and PRODUCT ADMINISTRATION ERROR (There was a large drop that went from the injection site down to my elbow). On 03-Jan-2022, ACCIDENTAL UNDERDOSE (I didn't get the full dose/I don't even think that he got the full dose in me) and PRODUCT ADMINISTRATION ERROR (There was a large drop that went from the injection site down to my elbow) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Arm is sore; A very bad headache all day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is sore) and HEADACHE (A very bad headache all day) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (First shot, lot number-EN6198, right dominant arm ) on 23-Feb-2021, PFIZER BIONTECH COVID-19 VACCINE (Second shot, lot number-EN6207 and Right dominant arm ) on 16-Mar-2021. Past adverse reactions to the above products included No adverse reaction with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 31-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2022, the patient experienced PAIN IN EXTREMITY (Arm is sore) and HEADACHE (A very bad headache all day). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm is sore) and HEADACHE (A very bad headache all day) outcome was unknown.            Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: has seen a lot of people with hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (has seen a lot of people with hives) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (has seen a lot of people with hives). At the time of the report, URTICARIA (has seen a lot of people with hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.  Reporter had seen an allergist and he had seen a lot of people with hives. Reporter states there is a ton of people approximately 1,000 + members that are in the group on social media who are primarily women around the age of 40.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Time between 1st and 2nd dose was 2 weeks; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time between 1st and 2nd dose was 2 weeks) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Arthritis and Thyroiditis. Concomitant products included ATENOLOL for Blood pressure management.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time between 1st and 2nd dose was 2 weeks). In April 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time between 1st and 2nd dose was 2 weeks) had resolved.            Other concomitant medication includes  Arthritis medication, Statin and Thyroid medication. No treatment medications were reported.   This case was linked to MOD-2022-437601 (Patient Link).
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 12 year old received a dose of Moderna; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received a dose of Moderna) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received a dose of Moderna). On 30-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old received a dose of Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: minor fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (minor fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (minor fever). At the time of the report, PYREXIA (minor fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment medications were reported.   This case was linked to MOD-2022-437875 (Patient Link).
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given a Moderna COVID 19 booster dose that has expired; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given a Moderna COVID 19 booster dose that has expired) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given a Moderna COVID 19 booster dose that has expired). On 03-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Patient was given a Moderna COVID 19 booster dose that has expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: arm was swelled; like someone had hit them in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm was swelled) and PAIN IN EXTREMITY (like someone had hit them in the arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm was swelled) and PAIN IN EXTREMITY (like someone had hit them in the arm). At the time of the report, PERIPHERAL SWELLING (arm was swelled) and PAIN IN EXTREMITY (like someone had hit them in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported. It was reported that arm was swelled like someone had hit them in the arm.   This case was linked to MOD-2022-437577, MOD-2022-437569, MOD-2022-437875, MOD-2022-437756 (Patient Link).   Reporter did not allow further contact
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site swelling
Clinical narrative: Rash; Swelling on injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and VACCINATION SITE SWELLING (Swelling on injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019F21A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Rash) and VACCINATION SITE SWELLING (Swelling on injection site). At the time of the report, RASH (Rash) and VACCINATION SITE SWELLING (Swelling on injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD-2022-437596 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Oropharyngeal pain, SARS-CoV-2 antibody test
Clinical narrative: a little bit of sore throat; The patient states she's been around people that have tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (a little bit of sore throat) and EXPOSURE TO SARS-COV-2 (The patient states she's been around people that have tested positive for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (a little bit of sore throat) and EXPOSURE TO SARS-COV-2 (The patient states she's been around people that have tested positive for COVID). At the time of the report, OROPHARYNGEAL PAIN (a little bit of sore throat) and EXPOSURE TO SARS-COV-2 (The patient states she's been around people that have tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jan-2022, SARS-CoV-2 antibody test: negative (Negative) Negative.         The patient had  been around people that have tested positive for COVID, but she doesn't know if they had it when she was around them. She was with them on Thursday 30-Dec-2021, but they tested positive on Friday 31-Dec-2021. No concomitant medications details were reported. No treatment information details were reported.   Reporter did not allow further contact
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site swelling
Clinical narrative: Swollen armpit at the arm of injection; Sore armpit at the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen armpit at the arm of injection) and AXILLARY PAIN (Sore armpit at the arm of injection) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swollen armpit at the arm of injection) and AXILLARY PAIN (Sore armpit at the arm of injection). At the time of the report, VACCINATION SITE SWELLING (Swollen armpit at the arm of injection) and AXILLARY PAIN (Sore armpit at the arm of injection) outcome was unknown.            No concomitant medications provided. No treatment medications provided.
Sex: U
Vaccine: COVID19
Symptoms: Osteoarthritis
Clinical narrative: Has the Modern a vaccine caused osteoarthritis; This spontaneous case was reported by an other health care professional and describes the occurrence of OSTEOARTHRITIS (Has the Modern a vaccine caused osteoarthritis) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OSTEOARTHRITIS (Has the Modern a vaccine caused osteoarthritis). At the time of the report, OSTEOARTHRITIS (Has the Modern a vaccine caused osteoarthritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.   No treatment information was provided by the reporter.   Reporter did not allow further contact
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 15 year old received Moderna 1st dose on accident; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna 1st dose on accident) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna 1st dose on accident). On 08-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna 1st dose on accident) had resolved.            No concomitant drug details were reported. No treatment details were reported.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: Anxiety, Lethargy, Lung disorder, Panic attack
Clinical narrative: Did make his lungs bleed a little bit; lethargic; Severe panic anxiety and panic attacks; Severe panic anxiety and panic attacks; This spontaneous case was reported by a consumer and describes the occurrence of LUNG DISORDER (Did make his lungs bleed a little bit), LETHARGY (lethargic), ANXIETY (Severe panic anxiety and panic attacks) and PANIC ATTACK (Severe panic anxiety and panic attacks) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LUNG DISORDER (Did make his lungs bleed a little bit), LETHARGY (lethargic), ANXIETY (Severe panic anxiety and panic attacks) and PANIC ATTACK (Severe panic anxiety and panic attacks). At the time of the report, LUNG DISORDER (Did make his lungs bleed a little bit), LETHARGY (lethargic), ANXIETY (Severe panic anxiety and panic attacks) and PANIC ATTACK (Severe panic anxiety and panic attacks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided. Patient has been not taking high blood pressure pills anymore.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Influenza like illness
Clinical narrative: got sick at the same time; flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick at the same time) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced ILLNESS (got sick at the same time). In 2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, ILLNESS (got sick at the same time) and INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown.            No concomitant medications were reported. Treatment none was reported.   This case was linked to MOD-2022-437834 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Influenza like illness, Pain, Vomiting
Clinical narrative: very intense flu-like symptoms; very sick; aches; chills; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (very intense flu-like symptoms), ILLNESS (very sick), PAIN (aches), CHILLS (chills) and VOMITING (vomiting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021 at 7:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021 at 7:00 AM, the patient experienced INFLUENZA LIKE ILLNESS (very intense flu-like symptoms), ILLNESS (very sick), PAIN (aches), CHILLS (chills) and VOMITING (vomiting). At the time of the report, INFLUENZA LIKE ILLNESS (very intense flu-like symptoms), ILLNESS (very sick), PAIN (aches), CHILLS (chills) and VOMITING (vomiting) was resolving.            It was reported that the symptoms got intense around 3 PM, and then it started to get better. Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2022-437865, MOD-2022-437822, MOD-2022-437834 (Patient Link).
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dyspnoea, Nasal congestion, Pyrexia
Clinical narrative: dry cough; congestion; breathing hard; lack of energy; mild fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough), NASAL CONGESTION (congestion), DYSPNOEA (breathing hard), ASTHENIA (lack of energy) and PYREXIA (mild fever) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 070L21A, 002C21A and 023C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (dry cough), NASAL CONGESTION (congestion), DYSPNOEA (breathing hard), ASTHENIA (lack of energy) and PYREXIA (mild fever). At the time of the report, COUGH (dry cough), NASAL CONGESTION (congestion), DYSPNOEA (breathing hard), ASTHENIA (lack of energy) and PYREXIA (mild fever) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Lymph node pain, Nasopharyngitis, Oropharyngeal pain, Pain
Clinical narrative: I am cold; Ache; Soar throat; I have sore lymph node in injection arm pit; Chills; This spontaneous case was reported by a pharmacist and describes the occurrence of NASOPHARYNGITIS (I am cold), PAIN (Ache), OROPHARYNGEAL PAIN (Soar throat), LYMPH NODE PAIN (I have sore lymph node in injection arm pit) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (I am cold), PAIN (Ache), OROPHARYNGEAL PAIN (Soar throat), LYMPH NODE PAIN (I have sore lymph node in injection arm pit) and CHILLS (Chills). At the time of the report, NASOPHARYNGITIS (I am cold), PAIN (Ache), OROPHARYNGEAL PAIN (Soar throat), LYMPH NODE PAIN (I have sore lymph node in injection arm pit) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Similar issues; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Similar issues) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Similar issues). At the time of the report, VACCINATION COMPLICATION (Similar issues) outcome was unknown.            No concomitant medication provided. No treatment medications provided.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: currently pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (currently pregnant) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Spontaneous abortion (During 1st dose of the Moderna Covid-19 vaccine, no genetic or any abnormalities were found that could have caused its fetal demise) on 26-Mar-2021.    On 14-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 28-Nov-2021 and the estimated date of delivery was 09-Sep-2022. On 14-Dec-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (currently pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  On 14-Dec-2021, MATERNAL EXPOSURE DURING PREGNANCY (currently pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication provided.   This case was linked to MOD-2022-437685 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-437865, MOD-2022-437824 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jan-2022: Updated patient demographics (Height, weight and race); anatomical site of vaccination (left arm) was added; updated action taken from the initial document.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: patent had hives 12 days after the booster dose/ hives were all over his body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (patent had hives 12 days after the booster dose/ hives were all over his body) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0361321A and 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2021, the patient experienced URTICARIA (patent had hives 12 days after the booster dose/ hives were all over his body). At the time of the report, URTICARIA (patent had hives 12 days after the booster dose/ hives were all over his body) outcome was unknown.            No concomitant medications were reported.  Patient had called to report side effects after he received Moderna vaccine. Patient reported that he had been dealing with hives since Christmas eve and stated that he had been dealing everyday and had been over a week at the time of the report. .After receiving the Moderna vaccine patient had to go to the urgent care and was prescribed steroids which he took for 2 days.   This case was linked to MOD-2022-437876 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: On December 18 I'm start having a very bad rush and itch; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH PRURITIC (On December 18 I'm start having a very bad rush and itch) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced RASH PRURITIC (On December 18 I'm start having a very bad rush and itch). At the time of the report, RASH PRURITIC (On December 18 I'm start having a very bad rush and itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.   Reporter did not allow further contact
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood gases, COVID-19, Chest X-ray abnormal, Cough, Intensive care
Clinical narrative: Covid19 breakthrough.  1st Vaccine received on 03/15/2021.  53 y/o with hx of ESRD on HD presented with respiratory distress, non productive cough. No fever or chills.  Noted to have sats in the 30% range on arrival.  Placed on NRB mask-O2 sats up to 94%.  CXR with pulm edema, Bilat effusions.  ABG obtained and pt placed on BIPAP.  Admitted to ICU and started on IV Abx/IV steroids and Remdesivir.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pleural effusion, Positive airway pressure therapy, Pulmonary oedema, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: Covid19 breakthrough.  1st Vaccine received on 03/15/2021.  53 y/o with hx of ESRD on HD presented with respiratory distress, non productive cough. No fever or chills.  Noted to have sats in the 30% range on arrival.  Placed on NRB mask-O2 sats up to 94%.  CXR with pulm edema, Bilat effusions.  ABG obtained and pt placed on BIPAP.  Admitted to ICU and started on IV Abx/IV steroids and Remdesivir.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st Vaccine received on 03/15/2021.  53 y/o with hx of ESRD on HD presented with respiratory distress, non productive cough. No fever or chills.  Noted to have sats in the 30% range on arrival.  Placed on NRB mask-O2 sats up to 94%.  CXR with pulm edema, Bilat effusions.  ABG obtained and pt placed on BIPAP.  Admitted to ICU and started on IV Abx/IV steroids and Remdesivir.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Postmenopausal haemorrhage
Clinical narrative: I had been post menopause for one year but after receiving my first shot started spotting 1 day later on and off .    2 weeks after the second shot started bleeding heavily and have now had 3 heavier than I have ever had periods 27/28 days apart
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Burning sensation, Condition aggravated, Erythema, Herpes simplex
Clinical narrative: Approx 14 hours after vaccination with 3rd dose (booster; primary vaccination series also Pfizer/BioNTech) developed a cold sore (HSV-1 recurrence) at left side and corner of upper lip (vermillion border extending to oral commissure). It consisted of erythematous pa pulse and a few vesicles.  It was associated with burning, numbness and tingling at the site of the rash/outbreak. Blistex medicated lip ointment was applied. This report has been made at the time of the event so no information is available at this time regarding the course of the event and or time to recovery.  There have been no new exposures other than vaccine. No recent HSV1 outbreaks in over 5 years.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Oral herpes, Papule, Paraesthesia
Clinical narrative: Approx 14 hours after vaccination with 3rd dose (booster; primary vaccination series also Pfizer/BioNTech) developed a cold sore (HSV-1 recurrence) at left side and corner of upper lip (vermillion border extending to oral commissure). It consisted of erythematous pa pulse and a few vesicles.  It was associated with burning, numbness and tingling at the site of the rash/outbreak. Blistex medicated lip ointment was applied. This report has been made at the time of the event so no information is available at this time regarding the course of the event and or time to recovery.  There have been no new exposures other than vaccine. No recent HSV1 outbreaks in over 5 years.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, COVID-19, Chills, Confusional state, Dizziness
Clinical narrative: GOT SHOT ON THAT WEDNESDAY MORNING. BY THAT NIGHT HAD CHILLS, CONFUSION, BODY ACHES, HEADACHE. NEXT DAY COULD NOT GET OUT OF BED DUE TO FATIGUE. I TOOK COVID TEST BECAUSE I THOUGHT SHOT WAS GIVEN TO ME ON TUESDAY AND SYMPTOMS WERE STILL SO SEVERE. IT WAS NEGATIVE. BY FRIDAY SYMPTOMS STILL GOING STRONG. I HAD NOT EATEN SINCE WEDNESDAY. I HAD UPSET STOMACH SHAKING DIZZINESS CINFUSION CHILLS BODY ACHES, ETC. SATURDAY MADE M YSELF TAKE SHOWER AND TRY AND MOVE AROUND. I WAS OUT OF BREATH AND DIZZY. SUNDAY WORN OUT TOOK ANOTHER HOME TEST IT WAS NEGATIVE. MONDAY WAS A LITTLE BETTER, NO CHILLS STILL TIRED. TUESDAY WOKE UP WITH HEADACHE, SON HAD SORE THROAT. WE BOTH WENT TO GET TESTED AND BOTH CAME BACK POSITIVE. I DONT KNOW WHEN IT STARTED FOR ME BECAUSE NOT SURE WHEN IT WENT FROM SIDE EFFECTS FROM BOOSTER TO COVID. I WAS FINE PRIOR TO THE SHOT TO THE BEST OF MY KNOWLEDGE.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, SARS-CoV-2 test positive, Tremor
Clinical narrative: GOT SHOT ON THAT WEDNESDAY MORNING. BY THAT NIGHT HAD CHILLS, CONFUSION, BODY ACHES, HEADACHE. NEXT DAY COULD NOT GET OUT OF BED DUE TO FATIGUE. I TOOK COVID TEST BECAUSE I THOUGHT SHOT WAS GIVEN TO ME ON TUESDAY AND SYMPTOMS WERE STILL SO SEVERE. IT WAS NEGATIVE. BY FRIDAY SYMPTOMS STILL GOING STRONG. I HAD NOT EATEN SINCE WEDNESDAY. I HAD UPSET STOMACH SHAKING DIZZINESS CINFUSION CHILLS BODY ACHES, ETC. SATURDAY MADE M YSELF TAKE SHOWER AND TRY AND MOVE AROUND. I WAS OUT OF BREATH AND DIZZY. SUNDAY WORN OUT TOOK ANOTHER HOME TEST IT WAS NEGATIVE. MONDAY WAS A LITTLE BETTER, NO CHILLS STILL TIRED. TUESDAY WOKE UP WITH HEADACHE, SON HAD SORE THROAT. WE BOTH WENT TO GET TESTED AND BOTH CAME BACK POSITIVE. I DONT KNOW WHEN IT STARTED FOR ME BECAUSE NOT SURE WHEN IT WENT FROM SIDE EFFECTS FROM BOOSTER TO COVID. I WAS FINE PRIOR TO THE SHOT TO THE BEST OF MY KNOWLEDGE.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Large swollen lymph node under left arm
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Discomfort, Oedema peripheral, Vaccine positive rechallenge
Clinical narrative: The morning after getting vaccinated my armpit got swollen almost the size of a tennis ball. It has been like that after 2 days of vaccination. It feels bothersome and a little painful scale 3. I experience this SE after the 2nd dose with the same vaccine.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Cough, Dyspnoea, Lung opacity
Clinical narrative: Covid19 breakthrough.  1st Vaccine received on 09/09/2021.  20 y/o female presented to ED with cough, worsening SOB, fever, congestion,myalagis, nausea/vomiting x4-5 days.  O2sat 84% on room air, T-102.2, tachycardic, tachypneic. Initially placed on 15L NRB mask but ultimately moved to BIPAP.  CXR with haxy and linear opacities R/L lung bases.  Started on IV Steroids/IV abx and Remdesivir.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Positive airway pressure therapy, Pyrexia, Respiratory tract congestion
Clinical narrative: Covid19 breakthrough.  1st Vaccine received on 09/09/2021.  20 y/o female presented to ED with cough, worsening SOB, fever, congestion,myalagis, nausea/vomiting x4-5 days.  O2sat 84% on room air, T-102.2, tachycardic, tachypneic. Initially placed on 15L NRB mask but ultimately moved to BIPAP.  CXR with haxy and linear opacities R/L lung bases.  Started on IV Steroids/IV abx and Remdesivir.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Tachycardia, Tachypnoea, Vaccine breakthrough infection, Vomiting
Clinical narrative: Covid19 breakthrough.  1st Vaccine received on 09/09/2021.  20 y/o female presented to ED with cough, worsening SOB, fever, congestion,myalagis, nausea/vomiting x4-5 days.  O2sat 84% on room air, T-102.2, tachycardic, tachypneic. Initially placed on 15L NRB mask but ultimately moved to BIPAP.  CXR with haxy and linear opacities R/L lung bases.  Started on IV Steroids/IV abx and Remdesivir.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site pain, Pain in extremity, Pyrexia, Sleep disorder
Clinical narrative: For 6 days after second Pfizer shot I had low fever 100.4 and body aches.   Injection arm has ached from my shoulder to my elbow since the injection.  Continually taking aspirin is the only thing that will help.   Since about a week after injection both hands go numb all the time.  Eating and sleeping is the worst times.  I?m continually waking up since the vaccine with my hands numb and hurting.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea
Clinical narrative: Diarrhea for 3 days.   Took OTC Psyllium Fiber Capsules per directions, which solved the problem.